NASDAQ
No price data available for this timeframe.
Nurix Therapeutics, Inc. (NRIX) has a current ratio of 7.02x as of Monday, May 25, 2026. This represents a 47.25% increase compared to its 12-month average of 4.77x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.